Michael Barbella, Managing Editor06.01.21
South Korea's renal dialysis market is forecast to grow 12.5 percent annually over the next four years, driven in part by the increasing use of hemodialysis machines and peritoneal dialysis (PD) for the treatment of end-stage renal disease (ESRD), according to GlobalData.
A recent report from the company reveals that hemodialysis machines accounted for more than 90 percent of the South Korean renal dialysis market in 2020.
Fresenius SE & Co KGaA was the leading player in the South Korean renal dialysis market last year, followed by B. Braun Melsungen AG. Together these two companies accounted for around 55 percent of the total market in 2020.
“With increase in the number of COVID-19 cases during the onset of the pandemic, people suffering from ESRD were impacted as they require regular dialysis care to survive," said Anusha Kaushik, a medical devices analyst at GlobalData. "During the pandemic, patients had access to dialysis centers and home-based equipment for continuous treatment. This has kept the demand afloat for renal dialysis equipment.”
Patients with renal disease will have weakened immune system and require continuous care as they are more susceptible to the virus. Increase in the aging population, high prevalence of diabetes mellitus, hypertension and vascular diseases are leading to the growth of ESRD, which in turn is driving the demand for renal dialysis equipment.
Dialysis treatment is preferred over transplant procedure for patients suffering from ESRD due to the shortage of donors and complexities associated with transplant procedure. The frequent need for dialysis and adoption of advanced technologies in medical institutions and development of better home dialysis equipment are expected to further boost the growth of renal dialysis equipment market in South Korea.
“The use of hemodialysis machines is high in South Korea. However, the growing demand for home-based care, increasing awareness of peritoneal dialysis, relatively high cost of hemodialysis at dialysis centers are expected to lead to the higher adoption rate of peritoneal dialysis in the future,” noted Kaushik.
A recent report from the company reveals that hemodialysis machines accounted for more than 90 percent of the South Korean renal dialysis market in 2020.
Fresenius SE & Co KGaA was the leading player in the South Korean renal dialysis market last year, followed by B. Braun Melsungen AG. Together these two companies accounted for around 55 percent of the total market in 2020.
“With increase in the number of COVID-19 cases during the onset of the pandemic, people suffering from ESRD were impacted as they require regular dialysis care to survive," said Anusha Kaushik, a medical devices analyst at GlobalData. "During the pandemic, patients had access to dialysis centers and home-based equipment for continuous treatment. This has kept the demand afloat for renal dialysis equipment.”
Patients with renal disease will have weakened immune system and require continuous care as they are more susceptible to the virus. Increase in the aging population, high prevalence of diabetes mellitus, hypertension and vascular diseases are leading to the growth of ESRD, which in turn is driving the demand for renal dialysis equipment.
Dialysis treatment is preferred over transplant procedure for patients suffering from ESRD due to the shortage of donors and complexities associated with transplant procedure. The frequent need for dialysis and adoption of advanced technologies in medical institutions and development of better home dialysis equipment are expected to further boost the growth of renal dialysis equipment market in South Korea.
“The use of hemodialysis machines is high in South Korea. However, the growing demand for home-based care, increasing awareness of peritoneal dialysis, relatively high cost of hemodialysis at dialysis centers are expected to lead to the higher adoption rate of peritoneal dialysis in the future,” noted Kaushik.
